Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Vaccinex, Inc. is a biotech company developing targeted biotherapeutics for neurodegenerative diseases, cancer, and autoimmune disorders. Its lead product, pepinemab, is an antibody targeting SEMA4D, aiming to modulate immune and inflammatory responses, promote tissue repair, and slow disease progression. The company leverages proprietary platforms like SEMA4D antibody and ActivMAb to address unmet medical needs in Alzheimer’s, Huntington’s, and various cancers.
This description was generated via AI from an annual report. Updated about 1 year ago.